Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review.
Global risk management in patients with type 2 diabetes mellitus.
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application.
Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient.
Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient. Clin Nephrol. 2002 Aug; 58(2):155-60.
View in:
PubMed
subject areas
Administration, Oral
Aged
Dose-Response Relationship, Drug
Ergocalciferols
Humans
Hyperparathyroidism, Secondary
Male
Parathyroid Hormone
Peritoneal Dialysis
authors with profiles
Stuart M. Sprague